BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 31, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Washington roundup: JAMA article lacks outcomes, but claims fusion is overused

April 8, 2010
By Mark McCarty

Washington roundup: Maisel cites data security in NEJM, but MITA, DoD are on it

April 7, 2010
By Mark McCarty

Washington roundup: PTO may double the term for provisional patent applications

April 5, 2010
By Mark McCarty

Washington roundup: FDA opens comment period for pediatric device data mandates

April 2, 2010
By Mark McCarty

Washington roundup: Nicholas acknowledges he is among authors of FDA letters

April 1, 2010
By Mark McCarty
GAITHERSBURG, Maryland — The FDA hearing on exposure to ionizing radiation in imaging scans included a roster of speakers who addressed a series of issues, but one theme emerged that gave both the agency and industry something to think about: several physicians who spoke bluntly informed both the agency and CT makers that they are not qualified to tell a doctor who should and should not get a scan, and furthermore that they are also not qualified to dictate dose. (Medical Device Daily)
Read More

Washington roundup: Berwick tapped to take over at CMS, but White House mum

March 30, 2010
By Mark McCarty

Washington roundup: Hospital, manufacturer snag twin warnings over MDRs

March 29, 2010
By Mark McCarty

Panel offers no new advice to FDA on nettlesome Menaflex

March 25, 2010
By Mark McCarty
GAITHERSBURG, Maryland – For the second time in 16 months, the orthopedics and rehabilitative devices advisory committee met to hear the case for and against the Menaflex 510(k), an application that in some minds is the poster child for all that is presumed to be wrong with the 510(k) process. (Medical Device Daily)
Read More

Panel: Revo, MRI compatible: FDA, Medtronic also friendly

March 23, 2010
By Mark McCarty

Washington roundup: House's healthcare reform bill tacks on 2.9% tax on devices

March 23, 2010
By Mark McCarty
The U.S. House of Representatives passed the landmark Patient Protection and Affordable Care Act of 2010 (H.R. 3590) late Sunday night by a vote of 219-212, earning just three votes more than the bare minimum needed for passage, and the majority party enjoyed a similar margin in passing the technical amendments in the form of H.R. 4872, dubbed the Health Care and Education Affordability Reconciliation Acts. (Medical Device Daily)
Read More
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 30, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing